Hims & Hers Health (HIMS) Appoints Anja Manuel to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
Citi Reiterates Buy Rating on Hims and Hers (HIMS)
May 20, 2024 11:49 AM EDTCiti analyst Daniel Grosslight reiterated a Buy rating and $16.00 price target on Hims and Hers (NYSE: HIMS)
The analyst comments "As widely anticipated, HIMS launched its GLP-1 offering this morning, which we think will significantly increase the interest in its weight loss offering.... More
